Repare Therapeutics Inc. financial data

Symbol
RPTX on Nasdaq
Industry
Pharmaceutical Preparations
Location
7171 Frederick Banting, Suite 270, Building 2, Saint Laurent, Quebec, Canada
State of incorporation
Canada (Federal Level)
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Mar 3, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 722 % +41.2%
Debt-to-equity 15.7 % -37.4%
Return On Equity -44.5 % -11.7%
Return On Assets -38.4 % -20.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 42.5M shares +0.15%
Common Stock, Shares, Outstanding 42.5M shares +0.79%
Entity Public Float 129M USD -66.3%
Common Stock, Value, Issued 487M USD +0.69%
Weighted Average Number of Shares Outstanding, Basic 42.4M shares +0.76%
Weighted Average Number of Shares Outstanding, Diluted 42.4M shares +0.76%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 116M USD -13.2%
General and Administrative Expense 29.7M USD -12.1%
Operating Income (Loss) -93.5M USD +19.5%
Nonoperating Income (Expense) 10.3M USD -21.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -83.2M USD +19.3%
Income Tax Expense (Benefit) 1.44M USD -100%
Net Income (Loss) Attributable to Parent -84.7M USD +9.71%
Earnings Per Share, Basic -2 USD/shares +10.3%
Earnings Per Share, Diluted -2 USD/shares +10.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 84.7M USD -23.9%
Marketable Securities, Current 68.1M USD -39.4%
Assets, Current 171M USD -29.8%
Property, Plant and Equipment, Net 2.29M USD -45.6%
Operating Lease, Right-of-Use Asset 1.92M USD -42.2%
Other Assets, Noncurrent 179K USD -54.8%
Assets 177M USD -30.5%
Accounts Payable, Current 3.62M USD +51%
Employee-related Liabilities, Current 5.62M USD -19.5%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 25.3M USD -35.3%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 88K USD -91.3%
Liabilities 25.4M USD -39.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax 54K USD +92.9%
Retained Earnings (Accumulated Deficit) -418M USD -25.4%
Stockholders' Equity Attributable to Parent 151M USD -28.7%
Liabilities and Equity 177M USD -30.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 11.9M USD
Net Cash Provided by (Used in) Financing Activities 375K USD -9.2%
Net Cash Provided by (Used in) Investing Activities -20.3M USD -204%
Common Stock, Shares, Issued 42.5M shares +0.79%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -8.05M USD +78.8%
Deferred Tax Assets, Valuation Allowance 140M USD +25.3%
Deferred Tax Assets, Gross 140M USD +25.3%
Operating Lease, Liability 1.93M USD -43.3%
Depreciation 501K USD +13.6%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -84.7M USD +9.3%
Lessee, Operating Lease, Liability, to be Paid 2M USD -43%
Property, Plant and Equipment, Gross 11.5M USD -0.18%
Operating Lease, Liability, Current 1.85M USD -23.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 88K USD -91.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.91M USD -23.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure +95.2%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 68K USD -33.3%
Deferred Tax Assets, Operating Loss Carryforwards 92.7M USD +32.6%
Preferred Stock, Shares Issued 0 shares
Unrecognized Tax Benefits 0 USD
Operating Lease, Payments 613K USD +2.34%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 23.2M USD -7.59%